Back to CVE records
Medium 6.7Published Feb 10, 2026

CVE-2025-35999Incorrect permission assignment for critical resource for some System Firmware Update Utility (SysFwUpdt) for Intel(R) Server Boards and Intel(R) Server Systems Based before version 16.0.12.

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

Incorrect permission assignment for critical resource for some System Firmware Update Utility (SysFwUpdt) for Intel(R) Server Boards and Intel(R) Server Systems Based before version 16.0.12. within Ring 3: User Applications may allow an escalation of privilege. System software adversary with a privileged user combined with a low complexity attack may enable escalation of privilege. This result may potentially occur via local access when attack requirements are present without special internal knowledge and requires passive user interaction. The potential vulnerability may impact the confidentiality (high), integrity (high) and availability (high) of the vulnerable system, resulting in subsequent system confidentiality (none), integrity (none) and availability (none) impacts.

CVSS
6.7 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-732
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Deferred
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.